| Dr Bradley Sklar, MD | |
|
116 Business Park Drive, 1st Floor, Utica, NY 13502-6313 | |
| (315) 624-7000 | |
| (315) 793-1129 |
| Full Name | Dr Bradley Sklar |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 36 Years |
| Location | 116 Business Park Drive, Utica, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003899261 | NPI | - | NPPES |
| 01407836 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 179332-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Faxton-st Luke's Healthcare | Utica, NY | Hospital |
| St Elizabeth Medical Center | Utica, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Digestive Disease Medicine Of Central New York, Llp | 1254351141 | 22 |
News Archive
Until now, attention-deficit/hyperactivity disorder (ADHD) was related to alterations in the brain affecting attention and cognitive processes. Researchers at Universitat Autònoma de Barcelona and the Vall d'Hebron University Hospital for the first time have discovered anomalies in the brain's reward system related to the neural circuits of motivation and gratification. In children with ADHD, the degree of motivation when carrying out an activity is related to the immediacy with which the objectives of the activity are met. This would explain why their attention and hyperactivity levels differ depending on the tasks being carried out.
Cognitive behavioral therapy delivered by respiratory nurses is cost-effective and reduces anxiety symptoms in chronic obstructive pulmonary disease patients, according to research published in ERJ Open Research.
Athough most artificial joints resemble the shape and structure of the joint they're designed to replace, one new prosthesis - the reverse shoulder - takes a different approach, reversing the position of the normal ball-and-socket design.
IPSOGEN SA today announces that two studies on the Genomic Grade test will be presented at the American Society for Clinical Oncology Annual Meeting, that will take place June 3-7, 2011, in Chicago, Ill, USA.
Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.
› Verified 9 days ago
| Entity Name | Digestive Disease Medicine Of Central New York, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083785372 PECOS PAC ID: 1254351141 Enrollment ID: O20051207000321 |
News Archive
Until now, attention-deficit/hyperactivity disorder (ADHD) was related to alterations in the brain affecting attention and cognitive processes. Researchers at Universitat Autònoma de Barcelona and the Vall d'Hebron University Hospital for the first time have discovered anomalies in the brain's reward system related to the neural circuits of motivation and gratification. In children with ADHD, the degree of motivation when carrying out an activity is related to the immediacy with which the objectives of the activity are met. This would explain why their attention and hyperactivity levels differ depending on the tasks being carried out.
Cognitive behavioral therapy delivered by respiratory nurses is cost-effective and reduces anxiety symptoms in chronic obstructive pulmonary disease patients, according to research published in ERJ Open Research.
Athough most artificial joints resemble the shape and structure of the joint they're designed to replace, one new prosthesis - the reverse shoulder - takes a different approach, reversing the position of the normal ball-and-socket design.
IPSOGEN SA today announces that two studies on the Genomic Grade test will be presented at the American Society for Clinical Oncology Annual Meeting, that will take place June 3-7, 2011, in Chicago, Ill, USA.
Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley Sklar, MD 116 Business Park Drive, 1st Floor, Utica, NY 13502-6313 Ph: (315) 624-7000 | Dr Bradley Sklar, MD 116 Business Park Drive, 1st Floor, Utica, NY 13502-6313 Ph: (315) 624-7000 |
News Archive
Until now, attention-deficit/hyperactivity disorder (ADHD) was related to alterations in the brain affecting attention and cognitive processes. Researchers at Universitat Autònoma de Barcelona and the Vall d'Hebron University Hospital for the first time have discovered anomalies in the brain's reward system related to the neural circuits of motivation and gratification. In children with ADHD, the degree of motivation when carrying out an activity is related to the immediacy with which the objectives of the activity are met. This would explain why their attention and hyperactivity levels differ depending on the tasks being carried out.
Cognitive behavioral therapy delivered by respiratory nurses is cost-effective and reduces anxiety symptoms in chronic obstructive pulmonary disease patients, according to research published in ERJ Open Research.
Athough most artificial joints resemble the shape and structure of the joint they're designed to replace, one new prosthesis - the reverse shoulder - takes a different approach, reversing the position of the normal ball-and-socket design.
IPSOGEN SA today announces that two studies on the Genomic Grade test will be presented at the American Society for Clinical Oncology Annual Meeting, that will take place June 3-7, 2011, in Chicago, Ill, USA.
Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.
› Verified 9 days ago
Elif N Erim, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2150 Bleecker St, Utica, NY 13501 Phone: 315-798-4955 Fax: 315-798-4740 | |
Nalini J Namassivaya, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 35 Riverside Dr, Utica, NY 13502 Phone: 315-735-2294 Fax: 315-735-2021 | |
Tracey Elizabeth Beard Hansel, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1656 Champlin Ave, Utica, NY 13502 Phone: 315-624-6467 Fax: 315-624-6469 | |
Emile Wassel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1450 Champlin Ave Ste 1, Utica, NY 13502 Phone: 315-624-9004 Fax: 315-624-9003 | |
Stanley Weiselberg, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 116 Business Park Drive, 1st Floor, Utica, NY 13502 Phone: 315-624-7000 Fax: 315-793-1129 | |
Susan Renee Garwood, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6 Hampden Pl, Utica, NY 13502 Phone: 315-624-3666 |